Loading
Latest filing published 18 Sept 2025 for Alphamab Oncology - B, €560k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
CHO Man is a declared insider of Alphamab Oncology - B, with filings sourced from HKEX. In total, 7 filings cover trades dated from 22 October 2024 to 15 September 2025.
On the open market, the record shows 2 purchases worth €83k and 4 sales worth €1.1M. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 2 purchases and 4 sales.
On 18 September 2025 came the latest disclosure, an open-market sale for €560k in Alphamab Oncology - B. The latest purchase dates back some time: it was published 467 days ago, on 14 July 2025. The median gap between a trade and its publication by HKEX is 3 days. Until a filing is published, the market cannot know about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations